期刊文献+

体外胶质瘤细胞原代培养对不同化疗药物敏感性初步研究 被引量:2

A Preliminary Study on Ex-vitro Drug Sensitivity Resistance Assay of Primary Culture Glioma cells
原文传递
导出
摘要 目的:观察7种抗肿瘤药物对体外原代培养的胶质瘤细胞的作用,为临床化疗方案的设计提供参考。方法:32例术后病理证实为胶质瘤的新鲜标本取材,制备肿瘤单细胞悬液进行体外原代培养,与肿瘤药DDP,VM-26,VP-16,BCNU,VCR,PCB,Taxol的临床血浆峰值浓度(PPC)作用72小时,MTT法检测不同肿瘤个体对不同化疗药物的敏感和耐药情况。结果:成功进行了32例临床标本的原代培养及药敏试验,其PPC下的抑制率(IR%)>50%者,DDP有14例;VCR有5例;VM-26有7例;VP-16有9例;PCB有3例;BCNU有2例;Taxol有1例;其敏感性依次为:DDP>VP-16>VM-26>VCR>PBZ>BCNU>Taxol。结论:7种常用的抗肿瘤药物均有耐药的情况,进行化疗药物的敏感测定可以避免耐药药物的使用,为提高临床化疗效果提供指导。 Objective: To carry out chemosensitivity experiment with the MTT assay aiming at providing theory guidance for clinical chemotherapy regimen Methods: 32 fresh specimen which were proved to be neurogliocytoma were used to produce monoplast suspension and carry out vitro primary culture, then seven antineoplastic drugs were added with peak plasma concentration to the primary culture glioma cells for 72 hours. Then the MTT colorimetric assay was employed to measure the survival tumor cell, to get the optical density and the inhibition ratio, and judge the sensitiveness and resistance to guide the clinical individual chemotherapy. ResultsL 32 clinical gliomas specimen were subject to primary culture and susceptibility test. The rank of sensitivity from high to low is: DDP〉 VP-16〉 VM-26〉VCR 〉PCB〉BCNU〉Taxol. Conclusions: Every one of 7 commonly used drugs has drug resistance. Chemosensitivity assay can avoid using the resistant drugs and provide guidance to improve the clinical chemotherapy effect.
出处 《现代生物医学进展》 CAS 2009年第6期1115-1116,1131,共3页 Progress in Modern Biomedicine
基金 云南省教育厅科研基金资助(No.06y132c)
关键词 脑胶质瘤 原代培养 MTT法 药敏试验 化学药物治疗 Neurogliocytoma Primary culture MTT Chemosensitivity test Chemotherapy
  • 相关文献

参考文献3

二级参考文献24

  • 1陈忠平.重视胶质瘤的化学治疗[J].中国神经肿瘤杂志,2003,1(2):65-68. 被引量:11
  • 2陈建文,张俊平,程金建,陈建良,史鸿浏,张俊英,牟永告,张湘衡,周旺宁,赛克,陈忠平.体外药敏试验指导的恶性脑胶质瘤预见性化疗[J].广东医学,2005,26(9):1183-1185. 被引量:17
  • 3Limburg H. Individual chemotherapy of ovarian cancer by means of tissue and culture method. Techniques and clinical application. London: Acadmic Press, 1972.295.
  • 4Chinot O. New place of the chemotherapy in gliomas. Bull Cancer, 2005,92(4):343.
  • 5Shibui S. Resent advances in chemotherapy for malignant brain tumors.Gan To Kagaku Ryoho, 2005,32(4):442.
  • 6Bobola MS, Silber JR, Ellenbogen RG, et al. O6 - methylguanine- DNA methyltransferase, O6 - benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines. Clin Cancer Res, 2005,11(7):2747.
  • 7Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med, 2005,352(10) :997.
  • 8Lang FF, Epstein FJ, Ransohoff J, et al. Central nervous system gangliogliomas. Part 2: Clinical outcome[J]. J Neurosurg, 1993, 79(6): 867-873.
  • 9Jordan JP, Hand CM, Markowita RS, et al. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay[J]. J Neurooncol, 1992, 14(1): 19-35.
  • 10Darling JL, Thomas DG. Response of short-term cultures derived from human malignant glioma to aziridinybenzoquinone, etoposide and doxorubicin: an in vitro phase Ⅱ trial [J]. Anticancer Drugs,2001, 12(9): 753-760.

共引文献40

同被引文献26

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部